JP2022532801A5 - - Google Patents
Info
- Publication number
- JP2022532801A5 JP2022532801A5 JP2021569297A JP2021569297A JP2022532801A5 JP 2022532801 A5 JP2022532801 A5 JP 2022532801A5 JP 2021569297 A JP2021569297 A JP 2021569297A JP 2021569297 A JP2021569297 A JP 2021569297A JP 2022532801 A5 JP2022532801 A5 JP 2022532801A5
- Authority
- JP
- Japan
- Prior art keywords
- substituted
- alkoxy
- alkyl
- alkylamino
- dialkylamino
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962851187P | 2019-05-22 | 2019-05-22 | |
| US62/851,187 | 2019-05-22 | ||
| PCT/US2020/034415 WO2020237225A1 (en) | 2019-05-22 | 2020-05-22 | Functionalized gold carbene naphthoquinone complexes for use in the treatment of cancer |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022532801A JP2022532801A (ja) | 2022-07-19 |
| JP2022532801A5 true JP2022532801A5 (enExample) | 2023-06-01 |
Family
ID=73459479
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021569297A Pending JP2022532801A (ja) | 2019-05-22 | 2020-05-22 | がんの治療において使用するための官能基化金カルベンナフトキノン錯体 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US12577262B2 (enExample) |
| EP (1) | EP3972981A4 (enExample) |
| JP (1) | JP2022532801A (enExample) |
| KR (1) | KR20220024123A (enExample) |
| CN (1) | CN114174305A (enExample) |
| AU (1) | AU2020279478A1 (enExample) |
| CA (1) | CA3140716A1 (enExample) |
| IL (1) | IL288176A (enExample) |
| MX (1) | MX2021014195A (enExample) |
| SG (1) | SG11202112856QA (enExample) |
| WO (1) | WO2020237225A1 (enExample) |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201003483D0 (en) | 2010-03-02 | 2010-04-14 | Univ St Andrews | Gold complexes |
| US8900654B2 (en) | 2011-07-29 | 2014-12-02 | Thin Film Electronics, Inc. | Methods of polymerizing silanes and cyclosilanes using N-heterocyclic carbenes, metal complexes having N-heterocyclic carbene ligands, and lanthanide compounds |
| PL2814829T3 (pl) | 2012-02-13 | 2017-06-30 | Bristol-Myers Squibb Company | Związki enediyny, ich koniugaty oraz zastosowanie i sposoby ich wytwarzania |
| WO2017083595A1 (en) | 2015-11-10 | 2017-05-18 | Massachusetts Institute Of Technology | Complexes comprising a platinum compound and an immune checkpoint inhibitor and related methods |
| WO2019006327A1 (en) * | 2017-06-30 | 2019-01-03 | Board Of Regents, The University Of Texas System | OR-CARBENE COMPLEXES CONTAINING NAPHTOQUINONE AND METHODS OF USE |
-
2020
- 2020-05-22 WO PCT/US2020/034415 patent/WO2020237225A1/en not_active Ceased
- 2020-05-22 JP JP2021569297A patent/JP2022532801A/ja active Pending
- 2020-05-22 US US17/595,670 patent/US12577262B2/en active Active
- 2020-05-22 SG SG11202112856QA patent/SG11202112856QA/en unknown
- 2020-05-22 AU AU2020279478A patent/AU2020279478A1/en not_active Abandoned
- 2020-05-22 CA CA3140716A patent/CA3140716A1/en active Pending
- 2020-05-22 MX MX2021014195A patent/MX2021014195A/es unknown
- 2020-05-22 KR KR1020217041752A patent/KR20220024123A/ko not_active Ceased
- 2020-05-22 CN CN202080050300.4A patent/CN114174305A/zh active Pending
- 2020-05-22 EP EP20809519.0A patent/EP3972981A4/en not_active Withdrawn
-
2021
- 2021-11-16 IL IL288176A patent/IL288176A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TWI868726B (zh) | 抗體-藥物結合物之新穎製造方法 | |
| JP7860665B2 (ja) | カンプトテシン系誘導体及びそのリガンド－薬物複合体 | |
| JP6854759B2 (ja) | 腫瘍微環境によって特異的活性化する小分子標的結合体およびその使用 | |
| WO2022078259A1 (zh) | 一种氘代的喜树碱衍生物及其抗体药物偶联物 | |
| CN115160403B (zh) | 特异性拓扑异构酶抑制剂和可用于抗体药物偶联物及其制备方法 | |
| BR112019008335A2 (pt) | conjugado de um anticorpo, composição farmacêutica e método para o tratamento e/ou a prevenção de um câncer | |
| TW202317199A (zh) | 配體藥物偶聯物及其應用 | |
| CN111001012A (zh) | 一种亲水碳酸酯型抗体偶联药物 | |
| WO2022126593A1 (zh) | 一种靶向trop2的抗体药物偶联物、其制备方法及应用 | |
| JP2021524439A5 (enExample) | ||
| CN113995846A (zh) | 聚乙二醇偶联药物增效剂、其制备方法及用途 | |
| CN113248475B (zh) | 一类杂环取代的苯并咪唑二聚体或其药学上可接受的盐、组合物及其用途 | |
| US20240269299A1 (en) | Polyethylene glycol-drug conjugate and use thereof | |
| WO2024230763A1 (zh) | 一种新型的靶向化合物和核酸缀合物，及其用途 | |
| CN101454309B (zh) | 焦谷氨酸衍生物的合成和用途 | |
| AU2008286742B2 (en) | Protein-polymer conjugates | |
| ES2255269T3 (es) | Subunidad b de la verotoxina para inmunizacion. | |
| WO2025130549A1 (zh) | 一种靶向整合素αvβ6的配体、缀合物、组合物以及它们的用途 | |
| US20250213645A1 (en) | Pharmaceutical composition for modulating immune response | |
| JP2018525346A5 (enExample) | ||
| CN121378257B (zh) | 靶向叶酸受体的化合物、组合物、其制备方法及应用 | |
| ES2910659T3 (es) | Nuevo derivado de PEG | |
| US20250325676A1 (en) | Camptothecin prodrug and pharmaceutical composition thereof | |
| TW202527988A (zh) | 光敏劑偶聯體化合物及其藥物組合物和應用 | |
| WO2025261479A1 (zh) | 以丁二酰基为连接链的偶联物及其制备方法和用途 |